Creatine ascorbates and a method of producing them
    1.
    发明授权
    Creatine ascorbates and a method of producing them 失效
    肌酸抗坏血酸盐及其生产方法

    公开(公告)号:US5863939A

    公开(公告)日:1999-01-26

    申请号:US898512

    申请日:1997-07-22

    IPC分类号: C07D307/62 A61K31/34

    CPC分类号: C07D307/62

    摘要: Creatine ascorbates are described which have the general formula (I)(creatine).sub.z (ascorbate).sub.y (H.sub.2 O).sub.n (I)wherez=1 to 100y=1 to 100 andn=0 to 20.These creatine ascorbates, which can be produced by way of the relatively simple reaction of creatine with ascorbic acid, can be used for enhancing muscular development and strength in the field of sport, as prophylactics against and for the treatment of conditions of oxygen deficit (ischemia) and as immune system stimulants in the field of health, for the treatment of muscular atrophy and as food supplements.

    摘要翻译: 描述了具有通式(I)(肌酸)z(抗坏血酸)y(H 2 O)n(I))的肌酸抗坏血酸酯,其中z = 1至100y = 1至100,n = 0至20.这些肌酸抗坏血酸酯, 可以通过肌酸与抗坏血酸的相对简单的反应来产生,可用于增强运动领域的肌肉发育和强度,作为预防和治疗氧缺乏(缺血)和免疫的情况 健康领域的系统兴奋剂,用于治疗肌肉萎缩和作为食物补充剂。

    Process for the production of 2-cyanoiminothiazolidine
    6.
    发明授权
    Process for the production of 2-cyanoiminothiazolidine 失效
    2-氰基亚氨基噻唑烷的制备方法

    公开(公告)号:US5591859A

    公开(公告)日:1997-01-07

    申请号:US509740

    申请日:1995-08-01

    申请人: Franz Thalhammer

    发明人: Franz Thalhammer

    IPC分类号: C07D277/18

    CPC分类号: C07D277/18

    摘要: A process for the production of 2-cyanoiminothiazolidine by reaction of 2-aminoethanethiol (cysteamine) with a dialkyl-N-cyanoimidocarbonate.

    摘要翻译: 通过2-氨基乙硫醇(半胱胺)与N-氰基亚氨基碳酸二烷基酯的反应制备2-氰基亚氨基噻唑烷的方法。

    Agent for the treatment of cast iron melts
    8.
    发明授权
    Agent for the treatment of cast iron melts 失效
    用于处理铸铁矿石的代理人

    公开(公告)号:US5209901A

    公开(公告)日:1993-05-11

    申请号:US861575

    申请日:1992-04-01

    IPC分类号: C22C35/00

    CPC分类号: C22C35/005

    摘要: Disclosed is an agent based on ferrosilicon for the treatment of cast iron melts before treatment with spheroidal graphite-inducing elements, especially magnesium, wherein, as additive elements, the agent additionally contains calcium, aluminum, manganese, zirconium, cerium and lanthanum. The content of iron plus silicon is at least 75% by weight with reference to the weight of all components and the elements zirconium, cerium and manganese additively are at least 5% by weight of the agent. The present invention also provides a process for the production of this agent, as well as a process for treating cast iron melts therewith.

    摘要翻译: 公开了一种用硅铁处理铸铁熔体的试剂,用球墨铸铁元素特别是镁处理,其中作为添加元素,该试剂另外含有钙,铝,锰,锆,铈和镧。 铁加硅的含量相对于所有组分的重量为至少75重量%,并且元素锆,铈和锰的添加量为该试剂的至少5重量%。 本发明还提供了一种制备该试剂的方法,以及用于处理铸铁熔体的方法。

    Process for the analytical determination of acetylcyanamide in urine
    9.
    发明授权
    Process for the analytical determination of acetylcyanamide in urine 失效
    尿液中乙酰氰胺的分析测定方法

    公开(公告)号:US5192690A

    公开(公告)日:1993-03-09

    申请号:US825645

    申请日:1992-01-21

    申请人: Ulrich Rust

    发明人: Ulrich Rust

    摘要: The present invention is directed to a process for the analytical determination of acetylcyanamide in urine. It involves (a) the separating of acetylcyanamide at from a urine matrix and/or an extract which is obtained from a urine matrix by ion exchange chromatography or reverse phase high performance liquid chromatography (HPLC), and (b) detecting the acetylcyanamide at a wavelength of 220 nm. The matrix or the extract of it is cleaned by treatment with activated carbon at pH 7 to 13, and the acetylcyanamide may be extracted from the cleaned matrix or its extract at pH 0.5 to 3.5, e.g. by liquid-liquid extraction of the acetylcyanamide. This is carried out by means of water-insoluble, organic solvent such as ethyl acetate or diethyl ether.

    摘要翻译: 本发明涉及尿中乙酰氰胺的分析测定方法。 它包括(a)通过离子交换色谱法或反相高效液相色谱法(HPLC)从尿基质和/或从尿液基质中获得的提取物分离出乙酰氰胺,和(b)检测乙酰氰胺 波长为220 nm。 通过在pH7至13的活性炭处理来清洗基质或其提取物,并且可以在pH为0.5至3.5的范围内从清洁的基质或其提取物中提取乙酰氰胺,例如, 通过液 - 液萃取乙酰氰胺。 这是通过不溶于水的有机溶剂如乙酸乙酯或乙醚进行的。